Good morning :)
Switch to
Place Order

Bal Pharma Ltd

BALPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹151 cr, stock is ranked 1,883
High RiskStock is 3.18x as volatile as Nifty
97.052.32% (-2.30)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹151 cr, stock is ranked 1,883
High RiskStock is 3.18x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
26.942.830.98%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
38.164.820.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bal Pharma Limited is engaged in the manufacture and sale of pharmaceutical products. The Company’s business comprises of Active Pharmaceutical Ingredients (API), Finished Formulations, Ayurvedic, Research and Development.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+226.02+172.94+251.67+286.37+3.80-12.22+4.74+5.61
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.43%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnAug 12, 2022

Bal Pharma Limited has informed the Exchange about press release dated 12-Aug-2022 titled Bal Pharma Ltd announces Q1FY23 financial results | Download

Bal Pharma Limited has informed the Exchange about press release dated 12-Aug-2022 titled Bal Pharma Ltd announces Q1FY23 financial results | Download

Outcome of Board Meeting 
Announced OnAug 11, 2022

Bal Pharma Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider financial statements for the period ended June 2022 | Download

Bal Pharma Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider financial statements for the period ended June 2022 | Download

Cash Dividend 
Ex. DateSep 16, 2021

Final • Div/Share: ₹ 1

See all events